PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
49.06
ESG score below 80% of RNAZ's 63.21. Jim Chanos would check for potential ESG-related litigation and regulatory risks.
63.54
Environmental score 1.1-1.2x RNAZ's 55.41. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
31.02
Social score below 80% of RNAZ's 67.22. Jim Chanos would check for potential social license and litigation risks.
52.63
Governance score below 80% of RNAZ's 67.01. Jim Chanos would check for potential agency conflicts and oversight failures.